Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Lesalpes29on Dec 07, 2022 8:21am
154 Views
Post# 35155701

RE:RE:RE:what is a barking dog?

RE:RE:RE:what is a barking dog?
Quentin30 wrote: Yup, anyone who questions either the relevance of his posts, or the potential value of ONCY is immediately a basher.

Today, more yet more stellar news is to be shared with ther biotech world, and their response is... as always... hmm,. interesting, but you need more patient data to prove this signals of efficacy are not just an aberration.

Beware the piumpers on here who continuously drip feed the insinuation that ONCY is worth billions to the next buyer... it is worth about 100 million and chump change.. and that is with being on the cusp of x2 phase III trials (one of which they have found no partner for in 5 years of seeking).

there is something rotten at the core of this company... and I would most certainly welcome a buyout, and get the f&*^ out of it with the shirt on my back.

Just when you think the tide is turning on this stock, and you average down, it falls even further - trade it or stay away, and you won't go hungry,.
And we have poster like you who has the truth and bash and bash and bash on every post. And it's like that because you have a lot money invested here! Fricking dummy! 

<< Previous
Bullboard Posts
Next >>